Clinical Interests: Evaluation of therapies that may potentially improve the pulmonary and neurodevelopmental outcomes of preterm and term infants. Foster interest of neonatal trainees in clinical research project design, management and completion.

Scholarly Focus: Clinical research activities that have the potential to improve the quality of life for NICU patients, not only while inpatients but also the long‐term improvement in their health. This focus includes the multiple clinical activities:

• Participation in studies that minimize the development of bronchopulmonary dysplasia such as inhaled nitric oxide, late surfactant treatment, and aerosolized surfactant administration to avoid need for intubation.
• Evaluation of whether high dose erythropoietin treatment has neuroprotective effects in pre‐ term and term infants.

Research Funding:

2013‐2021 Preterm Erythropoietin Neuroprotection Trial  (PENUT  Trial)  CCC.  1U01NS077953‐01 NINDS. Role: Co‐Investigator, Total Award: $10,145,741

2016‐2022 High‐dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC. 1U01NS092764‐ 01A1, NINDS. Role: Co‐Investigator, Total Award: $10,100,000

Administration/Education Roles: Design programs to educate future clinical researchers. Education responsibilities include training future pediatricians, neonatologists, neonatal nurse practitioners, and NICU nursing staff.